The bottom line is key. But companies can't keep eking out earnings gains without some growth on the top line. In the third quarter, revenue across the S&P 500 contracted 0.8%. This go-around, analysts forecast just 1.8% sales growth. But some companies do better. Much better. The IBD Screen Of The Day Top Fundamentals aggregates highly ranked firms with three-year EPS and sales growth of at least 25%. Here are the five leading stocks with the